amiodarone hydrochloride and lithium: what the product label says
Read the product-label passage naming lithium, with the source version, formulation and limitations.
The product label for potassium chloride names amiloride in its drug-interaction information. The complete selected section is reproduced below so that qualifications stay with the finding.
Potassium Chloride โ TABLET, FILM COATED, EXTENDED RELEASE โ ORAL
Labeled active ingredients: POTASSIUM CHLORIDE; POTASSIUM CATION. Routes: ORAL. Dosage forms: TABLET, FILM COATED, EXTENDED RELEASE.
Section: 7.1 Triamterene or amiloride
Use with triamterene or amiloride can produce severe hyperkalemia. Concomitant use is contraindicated [see Contraindications (4) ] .
Read the full product label on DailyMed. Label version 101, dated 2026-03-30.
This passage applies to the labeled product and circumstances it describes. It must not be generalized to other routes or formulations. It does not independently validate CDIโs severity category, establish safety for an individual, or replace the full label. The stored interaction description and classification have not been changed by this article.
Automatic checks matched drug identities, retrieved and preserved the label, and checked the full quoted section with AI assistance on 2026-11-03. The public explanation uses a fixed template; model-written medical advice is not published. Independent clinical review has not been recorded.
Ask your pharmacist or prescriber whether the cited products, routes and circumstances apply to your medicines before changing treatment.
CDI checks every pair across up to 20 drugs โ backed by FDA and NIH data.
Drug interaction data sourced from U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NLM), National Institutes of Health. For informational purposes only. Always consult your pharmacist or physician before making any medication decisions.
Read the product-label passage naming lithium, with the source version, formulation and limitations.
Read the product-label passage naming ritonavir, with the source version, formulation and limitations.
Read the product-label passage naming aliskiren, with the source version, formulation and limitations.